Unloxcyt: A New Horizon in Advanced Skin Cancer Treatment with Durable Responses and Manageable Safety
CHICAGO, IL – – Sun Pharmaceutical Industries, a global pharmaceutical leader, is poised to unveil critical updated long-term follow-up data for its innovative skin cancer drug, Unloxcyt (cosibelimab-ipdl), at the…
